Clinical Trials in Atlanta

Showing 12681-12700 of 19,805 trials

Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease

NCT03577691

The trial is a prospective, randomized study to determine the efficacy of training for use of a web based Decision Aid for Hydroxyurea(HU) usage among subjects with Sickle Cell Disease(SCD). Subjects are randomized primarily either to using a web based decision aid with training versus without training. Subjects in each group will be further randomized to 1) subjects receiving pretest surveys; and 2) subjects that do not receive pretest surveys.

Sickle Cell Disease

Emory University2 participantsStarted Aug 2018

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States

COMPLETEDNA< 1 mile

Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only

NCT02646579

The purpose of this study is to determine if dry needling both low back and extremity areas is more effective for reducing pain and improving strength, balance and functional performance among patients with chronic musculoskeletal conditions compared to dry needling of extremity areas only.

Plantar FasciitisAchilles TendinitisPatellofemoral Pain Syndrome

Emory University34 participantsStarted Oct 2017

Atlanta, Georgia, United States

Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease

Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only

Find Trials by Condition in Atlanta

Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

Clinical Study of WT2725 in Patients With Advanced Malignancies

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.